
OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
This special edition of the “Oncology Peer Review On-The-Go” podcast details treatment options and considerations for relapsed/refractory follicular lymphoma.
As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options and considerations for patients with relapsed/refractory follicular lymphoma (R/R FL).
In the video series, Gaballa discussed the following:
Treatment Options in Relapsed/Refractory Follicular Lymphoma Considerations for Treatment Selection in R/R FL Third-Line Therapy in Follicular Lymphoma Tazemetostat for Relapsed/Refractory Follicular Lymphoma R/R FL: The Role of PI3K Inhibitors Unmet Needs and Looking Ahead in Follicular Lymphoma
To watch more videos in CancerNetwork®’s OncView™ series, visit
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.